Cargando…
NAMPT Inhibitor and P73 Activator Represses P53 R175H Mutated HNSCC Cell Proliferation in a Synergistic Manner
The p53 family has the following three members: p53, p63 and p73. p53 is a tumor suppressor gene that frequently exhibits mutation in head and neck cancer. Most p53 mutants are loss-of-function (LoF) mutants, but some acquire some oncogenic function, such as gain of function (GoF). It is known that...
Autores principales: | Cai, Bi-He, Bai, Zhi-Yu, Lien, Ching-Feng, Yu, Si-Jie, Lu, Rui-Yu, Wu, Ming-Han, Wu, Wei-Chen, Chen, Chia-Chi, Hsu, Yi-Chiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946684/ https://www.ncbi.nlm.nih.gov/pubmed/35327630 http://dx.doi.org/10.3390/biom12030438 |
Ejemplares similares
-
P63 and P73 Activation in Cancers with p53 Mutation
por: Cai, Bi-He, et al.
Publicado: (2022) -
The Function of the Mutant p53-R175H in Cancer
por: Chiang, Yen-Ting, et al.
Publicado: (2021) -
CD73 is associated with poor prognosis in HNSCC
por: Ren, Zhen-Hu, et al.
Publicado: (2016) -
PTC124 Rescues Nonsense Mutation of Two Tumor Suppressor Genes NOTCH1 and FAT1 to Repress HNSCC Cell Proliferation
por: Wu, Ming-Han, et al.
Publicado: (2022) -
Synergistic activation of the NEU4 promoter by p73 and AP2 in colon cancer cells
por: Cai, Bi-He, et al.
Publicado: (2019)